2026 NPPES data Allergy Physician NPI 1881600948 M.D.
Verify on CMS →

CHARLES SHAPIRO, M.D.

Allergy Physician in BAYSIDE, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
566
Medicare Part D claims · 99 beneficiaries · Allergy Physician avg: 755
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.8K
81 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: CHARLES SHAPIRO, M.D. is a Allergy Physician ([object Object]) practicing in BAYSIDE, New York with a Medicare Part D prescribing footprint of 566 claims across 99 beneficiaries — 39% brand-name prescribing . Industry payments of $1.8K across 81 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: CHARLES SHAPIRO, M.D. filed 566 Medicare Part D claims in 2023 across BAYSIDE, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

CHARLES SHAPIRO, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

CHARLES SHAPIRO, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 07/31/2006

NPI 1881600948

Primary specialty

Allergy Physician

Niche

1,019 US NPIs in this specialty

Medicare Part D claims

566 25% vs specialty avg

2023 prescription claims

Specialty avg: 755

Specialty distribution in New York

How Allergy Physician compares to other specialties among New York providers

New York providers

Allergy Physician share within New York

1. Allergy Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Allergy Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Allergy Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Allergy Physician ABMS/AOA estimate

Est. board-certified rate (Allergy Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Allergy Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CHARLES SHAPIRO, M.D. is a Allergy Physician provider practicing in BAYSIDE, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1881600948. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

CHARLES SHAPIRO, M.D. appears in the CMS NPPES registry as a Allergy Physician provider holding M.D. credentials at 202-28 45TH AVENUE, BAYSIDE, NY, 11361, with a listed phone of (718) 224-7600. NPI 1881600948 was issued on 07/31/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SHAPIRO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 566 prescription claims written by this provider, covering 99 Medicare beneficiaries and totaling roughly $345K in drug spend, split 39% brand-name and 61% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Allergy Physician is a narrow specialty nationwide, with 1,019 enrolled providers across 49 states and an average of 755 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

202-28 45TH AVENUE
BAYSIDE, NY 11361

Provider Details

NPI 1881600948
Specialty Allergy Physician
Credentials M.D.
Gender Male
NPI Issued 07/31/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CHARLES SHAPIRO, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.8K

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to CHARLES SHAPIRO, M.D.. To verify CHARLES SHAPIRO, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

CHARLES SHAPIRO, M.D. — brand share 39.0%
Specialty average (est.)

39% brand-name claims vs 61% generic, on 566 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

566
Total Claims
$345K
Total Drug Cost
99
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
713
Total Day Supply
17,902
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$338K
Generic Drug Cost
$7K
Antibiotic Claims
57

Patient Demographics

Average Patient Age
68.5 years
Avg HCC Risk Score
1.05
Gender Split
74% female / 26% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
75
Albuterol Sulfate Hfa
Albuterol Sulfate
61
Methylprednisolone
50
Fluticasone Propionate
45
Prednisone
29
Azelastine Hcl
28
Famotidine
22
Azithromycin
21
Breztri Aerosphere
Budesonide/Glycopyr/Formoterol
20
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Allergy Physician Overview

How CHARLES SHAPIRO, M.D. fits within the Allergy Physician landscape nationally.

1,019
Allergy Physician Providers in US
49
States with Allergy Physician
755
Avg Claims per Provider

CHARLES SHAPIRO, M.D.'s 566 claims are below the specialty average of 755.

Nearby Allergy Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as SHAPIRO.

Compare Allergy Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CHARLES SHAPIRO, M.D.'s specialty?
CHARLES SHAPIRO, M.D. specializes in Allergy Physician and practices in BAYSIDE, New York. Credentials: M.D..
How much does CHARLES SHAPIRO, M.D. prescribe under Medicare Part D?
In 2023, CHARLES SHAPIRO, M.D. wrote 566 Medicare Part D claims totaling $345K in drug costs for 99 beneficiaries.
Where is CHARLES SHAPIRO, M.D. located?
CHARLES SHAPIRO, M.D. is located at 202-28 45TH AVENUE, BAYSIDE, NY, 11361. Phone: (718) 224-7600.
What is CHARLES SHAPIRO, M.D.'s NPI number?
CHARLES SHAPIRO, M.D.'s National Provider Identifier (NPI) is 1881600948, issued on 07/31/2006.
Does CHARLES SHAPIRO, M.D. prescribe more brand-name or generic drugs?
CHARLES SHAPIRO, M.D.'s prescribing is 39% brand-name and 61% generic drugs by claim count, with $338K in brand drug costs.
How many Allergy Physician providers are there in the US?
There are 1,019 Allergy Physician providers across 49 states in the US. The average Allergy Physician provider writes 755 Medicare Part D claims per year.
What drugs does CHARLES SHAPIRO, M.D. prescribe most often?
Based on 2023 Medicare Part D data, CHARLES SHAPIRO, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Methylprednisolone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CHARLES SHAPIRO, M.D. accept Medicare?
CHARLES SHAPIRO, M.D. appears in CMS Medicare data with 566 Part D claims and 99 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CHARLES SHAPIRO, M.D.'s credentials?
CHARLES SHAPIRO, M.D.'s NPI is 1881600948 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology